Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

N6-methyladenosine Modulates Nonsense-mediated mRNA Decay in Human Glioblastoma.

Li F, Yi Y, Miao Y, Long W, Long T, Chen S, Cheng W, Zou C, Zheng Y, Wu X, Ding J, Zhu K, Chen D, Xu Q, Wang J, Liu Q, Zhi F, Ren J, Cao Q, Zhao W.

Cancer Res. 2019 Sep 17. pii: canres.2868.2018. doi: 10.1158/0008-5472.CAN-18-2868. [Epub ahead of print]

PMID:
31530567
2.

METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer.

Yue B, Song C, Yang L, Cui R, Cheng X, Zhang Z, Zhao G.

Mol Cancer. 2019 Oct 13;18(1):142. doi: 10.1186/s12943-019-1065-4.

3.

RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.

Chen M, Wei L, Law CT, Tsang FH, Shen J, Cheng CL, Tsang LH, Ho DW, Chiu DK, Lee JM, Wong CC, Ng IO, Wong CM.

Hepatology. 2018 Jun;67(6):2254-2270. doi: 10.1002/hep.29683. Epub 2018 Apr 19.

PMID:
29171881
4.

Essential role of METTL3-mediated m6A modification in glioma stem-like cells maintenance and radioresistance.

Visvanathan A, Patil V, Arora A, Hegde AS, Arivazhagan A, Santosh V, Somasundaram K.

Oncogene. 2018 Jan 25;37(4):522-533. doi: 10.1038/onc.2017.351. Epub 2017 Oct 9.

PMID:
28991227
5.

N‚Ā∂-Methyladenosine Landscape of Glioma Stem-Like Cells: METTL3 Is Essential for the Expression of Actively Transcribed Genes and Sustenance of the Oncogenic Signaling.

Visvanathan A, Patil V, Abdulla S, Hoheisel JD, Somasundaram K.

Genes (Basel). 2019 Feb 13;10(2). pii: E141. doi: 10.3390/genes10020141.

6.

N6-methyladenosine METTL3 promotes the breast cancer progression via targeting Bcl-2.

Wang H, Xu B, Shi J.

Gene. 2019 Aug 24:144076. doi: 10.1016/j.gene.2019.144076. [Epub ahead of print]

PMID:
31454538
7.

METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism.

Xie W, Ma LL, Xu YQ, Wang BH, Li SM.

Biochem Biophys Res Commun. 2019 Oct 8;518(1):120-126. doi: 10.1016/j.bbrc.2019.08.018. Epub 2019 Aug 10.

PMID:
31405565
8.

SUMOylation of the m6A-RNA methyltransferase METTL3 modulates its function.

Du Y, Hou G, Zhang H, Dou J, He J, Guo Y, Li L, Chen R, Wang Y, Deng R, Huang J, Jiang B, Xu M, Cheng J, Chen GQ, Zhao X, Yu J.

Nucleic Acids Res. 2018 Jun 1;46(10):5195-5208. doi: 10.1093/nar/gky156.

9.

The m6A methyltransferase METTL3 promotes osteosarcoma progression by regulating the m6A level of LEF1.

Miao W, Chen J, Jia L, Ma J, Song D.

Biochem Biophys Res Commun. 2019 Aug 27;516(3):719-725. doi: 10.1016/j.bbrc.2019.06.128. Epub 2019 Jun 26.

PMID:
31253399
10.

METTL3 regulates alternative splicing of MyD88 upon the lipopolysaccharide-induced inflammatory response in human dental pulp cells.

Feng Z, Li Q, Meng R, Yi B, Xu Q.

J Cell Mol Med. 2018 May;22(5):2558-2568. doi: 10.1111/jcmm.13491. Epub 2018 Mar 4.

11.

METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma.

Li T, Hu PS, Zuo Z, Lin JF, Li X, Wu QN, Chen ZH, Zeng ZL, Wang F, Zheng J, Chen D, Li B, Kang TB, Xie D, Lin D, Ju HQ, Xu RH.

Mol Cancer. 2019 Jun 24;18(1):112. doi: 10.1186/s12943-019-1038-7.

12.

Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase.

Ping XL, Sun BF, Wang L, Xiao W, Yang X, Wang WJ, Adhikari S, Shi Y, Lv Y, Chen YS, Zhao X, Li A, Yang Y, Dahal U, Lou XM, Liu X, Huang J, Yuan WP, Zhu XF, Cheng T, Zhao YL, Wang X, Rendtlew Danielsen JM, Liu F, Yang YG.

Cell Res. 2014 Feb;24(2):177-89. doi: 10.1038/cr.2014.3. Epub 2014 Jan 10.

13.

METTL3-mediated m6A modification is required for cerebellar development.

Wang CX, Cui GS, Liu X, Xu K, Wang M, Zhang XX, Jiang LY, Li A, Yang Y, Lai WY, Sun BF, Jiang GB, Wang HL, Tong WM, Li W, Wang XJ, Yang YG, Zhou Q.

PLoS Biol. 2018 Jun 7;16(6):e2004880. doi: 10.1371/journal.pbio.2004880. eCollection 2018 Jun.

14.

Changes of N6-methyladenosine modulators promote breast cancer progression.

Wu L, Wu D, Ning J, Liu W, Zhang D.

BMC Cancer. 2019 Apr 5;19(1):326. doi: 10.1186/s12885-019-5538-z.

15.

METTL3 promotes experimental osteoarthritis development by regulating inflammatory response and apoptosis in chondrocyte.

Liu Q, Li M, Jiang L, Jiang R, Fu B.

Biochem Biophys Res Commun. 2019 Aug 13;516(1):22-27. doi: 10.1016/j.bbrc.2019.05.168. Epub 2019 Jun 8.

PMID:
31186141
16.

The epitranscriptome m6A writer METTL3 promotes chemo- and radioresistance in pancreatic cancer cells.

Taketo K, Konno M, Asai A, Koseki J, Toratani M, Satoh T, Doki Y, Mori M, Ishii H, Ogawa K.

Int J Oncol. 2018 Feb;52(2):621-629. doi: 10.3892/ijo.2017.4219. Epub 2017 Dec 7.

PMID:
29345285
17.

Expression profiles and prognostic significance of RNA N6-methyladenosine-related genes in patients with hepatocellular carcinoma: evidence from independent datasets.

Zhou Y, Yin Z, Hou B, Yu M, Chen R, Jin H, Jian Z.

Cancer Manag Res. 2019 May 1;11:3921-3931. doi: 10.2147/CMAR.S191565. eCollection 2019.

18.

Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer.

Liu T, Yang S, Sui J, Xu SY, Cheng YP, Shen B, Zhang Y, Zhang XM, Yin LH, Pu YP, Liang GY.

J Cell Physiol. 2020 Jan;235(1):548-562. doi: 10.1002/jcp.28994. Epub 2019 Jun 24.

PMID:
31232471
19.

N6-methyladenosine contributes to cellular phenotype in a genetically-defined model of breast cancer progression.

Fry NJ, Law BA, Ilkayeva OR, Carraway KR, Holley CL, Mansfield KD.

Oncotarget. 2018 Jul 27;9(58):31231-31243. doi: 10.18632/oncotarget.25782. eCollection 2018 Jul 27.

20.

The N6-Methyladenosine mRNA Methylase METTL3 Controls Cardiac Homeostasis and Hypertrophy.

Dorn LE, Lasman L, Chen J, Xu X, Hund TJ, Medvedovic M, Hanna JH, van Berlo JH, Accornero F.

Circulation. 2019 Jan 22;139(4):533-545. doi: 10.1161/CIRCULATIONAHA.118.036146.

Supplemental Content

Support Center